Not available
Quote | Willis Towers Watson Public Limited Company (NASDAQ:WLTW)
Last: | $231.56 |
---|---|
Change Percent: | -1.19% |
Open: | $233.05 |
Close: | $231.56 |
High: | $235.5 |
Low: | $231.26 |
Volume: | 1,227,082 |
Last Trade Date Time: | 01/07/2022 04:55:53 pm |
News | Willis Towers Watson Public Limited Company (NASDAQ:WLTW)
SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of James Baum as WTW Head of Australia and New Zealand, and Head of Corporate Risk & Broking (CRB) Australia and New Zealand, effective 15 Ju...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- WTW, a leading global advisory, broking, and solutions company has published its second annual sustainability report, Taking Action to Create Sustainable Value, outlining the company’s sustainability programs, commitments and accomplishments....
Message Board Posts | Willis Towers Watson Public Limited Company (NASDAQ:WLTW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Willis Towers Watson Public Limited Company Company Name:
WLTW Stock Symbol:
NASDAQ Market:
SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of James Baum as WTW Head of Australia and New Zealand, and Head of Corporate Risk & Broking (CRB) Australia and New Zealand, effective 15 Ju...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- WTW, a leading global advisory, broking, and solutions company has published its second annual sustainability report, Taking Action to Create Sustainable Value, outlining the company’s sustainability programs, commitments and accomplishments....
LONDON, June 27, 2024 (GLOBE NEWSWIRE) -- 63% of life science companies believe the high cost of new drug development is among the emerging themes that will have the greatest negative impact on the sector in the next 3-5 years, according to Global life science risk report 2024 published t...